Park Jae Hong, Faller Douglas V
Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Virology. 2002 Nov 25;303(2):345-63. doi: 10.1006/viro.2002.1638.
Epstein-Barr virus (EBV) latent membrane protein (LMP)-1 induces B lymphocyte immortalization and activates constitutive signal transduction, including NF-kappaB, JNK/p38, and JAK/STAT pathways. During EBV latency, LMP-1 expression induces several B lymphocyte activation markers, including intercellular adhesion molecule (ICAM)-1. We found that various structurally distinct histone deacetylase inhibitors (HDACI), as well as phorbol ester treatment, induced homotypic aggregation in EBV-positive Burkitt's lymphoma lines. Cell-surface expression of ICAM-1 was concurrently strongly up-regulated by both HDACI and phorbol ester treatments. Cell-surface expression of ICAM-1 was concurrently strongly induced by both HDACI and phorbol ester treatment. Among several ICAM family members, only ICAM-1 was up-regulated by both HDACI and phorbol ester treatments, suggesting that up-regulated ICAM-1 expression might mediate the observed increase in homotypic aggregation. HDACI-induced homotypic aggregation was blocked by exposure to a monoclonal antibody specific for the beta-chain (CD18) of an ICAM-1 ligand, LFA-1. Unexpectedly, HDAC inhibition, but not phorbol ester treatment, induced LMP-1 expression in EBV-positive cell lines, and this LMP-1 species was identified by RT-PCR and immunoblot analyses as the latent form of LMP-1. Control of EBV LMP-1 gene expression by HDACI inhibition occurs at the transcriptional level, as indicated by nuclear runoff studies and analysis of steady-state mRNA levels. Dominant-negative LMP-1 efficiently blocked HDACI-induced ICAM-1 up-regulation, and ectopic expression of LMP-1 activated expression of an ICAM-1 promoter-driven reporter gene. The HDACI-induced up-regulation of ICAM-1, and consequent homotypic aggregation, were efficiently blocked by the addition of N-acetyl-L-cysteine and by ectopic expression of a super-repressor IkappaBalpha, while LPM-1 induction was unaffected, suggesting that these effects are mediated by NF-kappaB. We demonstrate, therefore, that the latent isoform of LMP-1 is induced by HDAC inhibition, and that HDACI-induced latent LMP-1 expression, through NF-kappaB activation, is responsible for ICAM-1 expression up-regulation and homotypic adhesion.
爱泼斯坦-巴尔病毒(EBV)潜伏膜蛋白(LMP)-1可诱导B淋巴细胞永生化,并激活包括核因子κB、JNK/p38和JAK/STAT通路在内的组成型信号转导。在EBV潜伏期间,LMP-1表达可诱导多种B淋巴细胞激活标志物,包括细胞间黏附分子(ICAM)-1。我们发现,各种结构不同的组蛋白去乙酰化酶抑制剂(HDACI)以及佛波酯处理,可诱导EBV阳性伯基特淋巴瘤细胞系发生同型聚集。HDACI和佛波酯处理均同时强烈上调ICAM-1的细胞表面表达。HDACI和佛波酯处理均同时强烈诱导ICAM-1的细胞表面表达。在几种ICAM家族成员中,只有ICAM-1在HDACI和佛波酯处理下均上调,这表明上调的ICAM-1表达可能介导了观察到的同型聚集增加。HDACI诱导的同型聚集可被暴露于针对ICAM-1配体LFA-1的β链(CD18)的单克隆抗体所阻断。出乎意料的是,HDAC抑制而非佛波酯处理可在EBV阳性细胞系中诱导LMP-1表达,并且通过RT-PCR和免疫印迹分析鉴定该LMP-1为LMP-1的潜伏形式。如核转录分析和稳态mRNA水平分析所示,HDACI抑制对EBV LMP-1基因表达的调控发生在转录水平。显性负性LMP-1有效阻断HDACI诱导的ICAM-1上调,而LMP-1的异位表达激活了ICAM-1启动子驱动的报告基因的表达。添加N-乙酰-L-半胱氨酸和异位表达超抑制因子IkappaBalpha可有效阻断HDACI诱导的ICAM-1上调及随之而来的同型聚集,而LPM-1诱导不受影响,这表明这些效应是由核因子κB介导的。因此,我们证明LMP-1的潜伏异构体是由HDAC抑制诱导的,并且HDACI诱导的潜伏LMP-1表达通过核因子κB激活,导致ICAM-1表达上调和同型黏附。